Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cora N Sternberg

Showing results (31-40 of 357) with videos related to

Pageof 36
Sort By:
Nature Clinical Practice. Urology|February 1, 2007
Multidisciplinary management of bone complications in prostate cancer and optimizing outcomes of bisphosphonate therapyFred Saad, Cora N Sternberg
BJU International|August 24, 2006
What has been learned from meta-analyses of neoadjuvant and adjuvant chemotherapy in bladder cancer?Cora N Sternberg, Laurence Collette
Translational Cancer Research|June 18, 2025
Does circulating DNA tumor fraction add value to prostate-specific antigen in metastatic castration-resistant prostate cancer?Cora N Sternberg, Maha Hussain
European Urology|February 4, 2014
Thoughts on a systematic review and meta-analysis of adjuvant chemotherapy in muscle-invasive bladder cancerCora N Sternberg, Richard Sylvester
Current Treatment Options in Oncology|August 27, 2002
Localized and locally advanced bladder cancerFabio Calabrò, Cora N Sternberg
International Journal of Urology : Official Journal of the Japanese Urological Association|January 22, 2010
The role of docetaxel based therapy for prostate cancer in the era of targeted medicineGuru Sonpavde, Cora N Sternberg
BJU International|November 28, 2008
Treatment of metastatic urothelial cancer: opportunities for drug discovery and developmentGuru Sonpavde, Cora N Sternberg
European Urology|November 4, 2008
Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancerFabio Calabrò, Cora N Sternberg
Translational Andrology and Urology|January 28, 2016
Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancerFederica Recine, Cora N Sternberg
Critical Reviews in Oncology/Hematology|September 18, 2016
Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamideGiulia Baciarello, Cora N Sternberg
Pageof 36

Showing results (31-40 of 357) with videos related to

Sort By:
Pageof 36
Nature Clinical Practice. Urology|February 1, 2007
Multidisciplinary management of bone complications in prostate cancer and optimizing outcomes of bisphosphonate therapyFred Saad, Cora N Sternberg
BJU International|August 24, 2006
What has been learned from meta-analyses of neoadjuvant and adjuvant chemotherapy in bladder cancer?Cora N Sternberg, Laurence Collette
Translational Cancer Research|June 18, 2025
Does circulating DNA tumor fraction add value to prostate-specific antigen in metastatic castration-resistant prostate cancer?Cora N Sternberg, Maha Hussain
European Urology|February 4, 2014
Thoughts on a systematic review and meta-analysis of adjuvant chemotherapy in muscle-invasive bladder cancerCora N Sternberg, Richard Sylvester
Current Treatment Options in Oncology|August 27, 2002
Localized and locally advanced bladder cancerFabio Calabrò, Cora N Sternberg
International Journal of Urology : Official Journal of the Japanese Urological Association|January 22, 2010
The role of docetaxel based therapy for prostate cancer in the era of targeted medicineGuru Sonpavde, Cora N Sternberg
BJU International|November 28, 2008
Treatment of metastatic urothelial cancer: opportunities for drug discovery and developmentGuru Sonpavde, Cora N Sternberg
European Urology|November 4, 2008
Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancerFabio Calabrò, Cora N Sternberg
Translational Andrology and Urology|January 28, 2016
Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancerFederica Recine, Cora N Sternberg
Critical Reviews in Oncology/Hematology|September 18, 2016
Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamideGiulia Baciarello, Cora N Sternberg
Pageof 36